NFP
ABBV icon

Narus Financial Partners’s AbbVie ABBV Stock Holding History

Narus Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$601K Buy
2,388
+79
+3% +$17K 0.15% 94
2026
Q1 		$502K Buy
2,309
+205
+10% +$45.5K 0.13% 100
2025
Q4 		$481K Buy
2,104
+9
+0.4% +$2.05K 0.13% 97
2025
Q3 		$485K Buy
2,095
+75
+4% +$15.3K 0.13% 97
2025
Q2 		$375K Buy
2,020
+32
+2% +$5.95K 0.12% 102
2025
Q1 		$417K Buy
1,988
+401
+25% +$78K 0.14% 87
2024
Q4 		$282K Sell
1,587
-821
-34% -$151K 0.1% 121
2024
Q3 		$476K Buy
2,408
+187
+8% +$34.9K 0.17% 82
2024
Q2 		$381K Buy
2,221
+222
+11% +$36.8K 0.15% 92
2024
Q1 		$364K Buy
1,999
+124
+7% +$21.4K 0.16% 98
2023
Q4 		$291K Buy
1,875
+196
+12% +$28.6K 0.14% 105
2023
Q3 		$250K Buy
1,679
+136
+9% +$20K 0.13% 103
2023
Q2 		$208K Buy
1,543
+2
+0.1% +$293 0.11% 113
2023
Q1 		$246K Hold
1,541
– – 0.13% 100
2022
Q4 		$249K Buy
+1,541
New +$236K 0.14% 98
2022
Q2 		– Sell
-1,420
Closed -$230K – 113
2022
Q1 		$230K Buy
+1,420
New +$206K 0.13% 100
2017
Q3 		$223K Buy
+2,512
New +$191K 0.2% 70

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Narus Financial Partners's ABBV Position: Q2 2026 in Review

Narus Financial Partners increased its AbbVie (ABBV) stake by 3.4% in Q2 2026, buying an estimated $17K and bringing the position to 2,388 shares worth $601K. The position accounts for 0.15% of the portfolio, ranked #94.

Narus Financial Partners first reported a position in ABBV in Q3 2017 and has held it in 17 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Narus Financial Partners held 2,388 shares of AbbVie worth $601K as of Q2 2026.
  • Narus Financial Partners bought 79 AbbVie shares in Q2 2026, an estimated $17K.
  • AbbVie made up 0.15% of Narus Financial Partners's portfolio in Q2 2026, its #94 holding.
  • Narus Financial Partners first reported a position in AbbVie in Q3 2017 and has held it in 17 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Narus Financial Partners's 13F filing for Q2 2026, filed 31 Jul 2026.